Volume 13, Number 1—January 2007
Research
Vaccine Effectiveness Estimates, 2004–2005 Mumps Outbreak, England
Table 3
Age-specific estimates of vaccine effectiveness for 1 and 2 doses of measles, mumps, rubella vaccine
Age group, y | Effectiveness | |
---|---|---|
1 dose, % (95% CI*) | 2 doses, % (95% CI*) | |
2 | 95.9 (81.1–99.1) | – |
5–6 | 93.8 (84.1–97.6) | 98.8 (97.0–99.5) |
7–8 | 90.3 (81.2–95.0) | 95.8 (92.9–97.5) |
9–10 | 86.5 (75.3–92.6) | 92.4 (87.7–95.3) |
11–12 | 65.9 (30.3–83.3) | 86.4 (74.1–92.9) |
*CI, confidence interval; p for linear trend <0.001 for 1 and 2 doses.
1Current affiliations: National Institute for Communicable Diseases, Johannesburg, South Africa, and University of the Witwatersrand School of Public Health, Parktown, South Africa